HEPHAISTOS sécurise 10,3 M€ pour aller jusqu’en clinique
May 16, 2024 00:00 ET
|
Hephaistos Pharma
Communiqué : HEPHAISTOS sécurise 10,3 M€ pour aller jusqu’en clinique HEPHAISTOS-Pharma accueille Elaia qui boucle son tour d’amorçage, sécurisant ainsi un total de 10,3 millions d'euros, entre...
Vaccinex Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15, 2024 18:00 ET
|
Vaccinex, Inc.
Last patient last visit in SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease in early June 2024. $8.2 million of new financing in Q1.
Mitsubishi HC Capital America and Electrada Partner to Provide EV Charging-as-a-Service for Vehicle OEMs and Commercial Customers
May 15, 2024 08:02 ET
|
Mitsubishi HC Capital America
NORWALK, Conn., May 15, 2024 (GLOBE NEWSWIRE) -- Despite a recent growth forecast of 27.5% CAGR and the size of the electric vehicle (EV) charging infrastructure market estimated to exceed $224.8...
Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives
May 10, 2024 17:40 ET
|
Tevogen Bio Inc
$50 million in financing advances operational objectives and bolsters a financial path to positive cashflow with minimal dilution.
R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO
May 09, 2024 12:00 ET
|
R3 Vascular
R3 Vascular, Inc. announced the closing of its $87 million Series B financing round and the appointment of a new President and Chief Executive Officer
Attovia Therapeutics Raises $105 Million Oversubscribed Series B Financing Led by Goldman Sachs Alternatives
May 09, 2024 07:30 ET
|
Attovia Therapeutics, Inc.
-- Proceeds support advancing Attovia’s lead programs through initial clinical readouts, expanding its pipeline, and ongoing development of the ATTOBODY™ platform -- Financing led by Goldman Sachs...
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
May 07, 2024 07:00 ET
|
Eledon Pharmaceuticals, Inc.
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement
Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules
May 02, 2024 16:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Revival Gold Announces Closing of Previously Announced Brokered Equity Financing and Update on Ensign Acquisition
May 02, 2024 12:06 ET
|
Revival Gold Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, May 02, 2024 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival...
Standard Uranium Announces Davidson River Drill Program Private Placement for Up to C$3.0 Million & Share Consolidation
May 02, 2024 07:00 ET
|
Standard Uranium Ltd.
STANDARD URANIUM ANNOUNCES DAVIDSON RIVER DRILL PROGRAM PRIVATE PLACEMENT FOR UP TO C$3.0 MILLION & SHARE CONSOLIDATION